1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazole → 8-bromo-2-[2-(2,2,2-trifluoro-ethyl)-2H-[1,2,4]triazol-3-yl]-4,5-dihydro-6-oxa-1,3a-diaza-benzo[e]azulene
Reaction equation
[Br:1][C:2]1[CH:16]=[CH:15][C:5]2[C:6]3[N:7]([CH:11]=[C:12](I)[N:13]=3)[CH2:8][CH2:9][O:10][C:4]=2[CH:3]=1.[F:17][C:18]([F:26])([F:25])[CH2:19][N:20]1[CH:24]=[N:23][CH:22]=[N:21]1>>[Br:1][C:2]1[CH:16]=[CH:15][C:5]2[C:6]3[N:7]([CH:11]=[C:12]([C:24]4[N:20]([CH2:19][C:18]([F:26])([F:25])[F:17])[N:21]=[CH:22][N:23]=4)[N:13]=3)[CH2:8][CH2:9][O:10][C:4]=2[CH:3]=1Participants
3
Procedure
Following the procedure for 184, 9-bromo-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine and 1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazole were reacted to give 9-bromo-2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine (0.109 g, 10%). 1H NMR (400 MHz, DMSO) δ 8.28 (t, J=21.9, 1H), 8.11 (t, J=7.9, 2H), 7.51-7.35 (m, 1H), 7.32 (d, J=2.0, 1H), 5.88 (q, J=8.8, 2H), 4.76-4.29 (m, 4H). MS (ESI(+)): m/z 413.9 (M+H).
Workup
- customwere reacted
Sources & evidence
- ORD record
- ord-612395a4363445c0971521a5e44094a6
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08785626B2
Reaction notes
Loading…